Structural and functional characterization of the first intracellular loop of human thromboxane A2 receptor.

The conformation of a constrained peptide mimicking the putative first intracellular domain (iLP1) of thromboxane A(2) receptor (TP) was determined by (1)H 2D NMR spectroscopy. Through completed assignments of TOCSY, DQF-COSY, and NOESY spectra, a NMR structure of the peptide showed a beta-turn in residues 56-59 and a short helical structure in the residues 63-66. It suggests that residues 63-66 may be part of the second transmembrane domain (TM), and that Arg60, in an exposed position on the outer surface of the loop, may be involved in signaling through charge contact with Gq protein. The sequence alignment of Lys residue in the same position of other prostanoid receptors mediates different G protein couplings, suggesting that the chemical properties of Arg and Lys may also affect the receptor signaling activity. These hypotheses were supported by mutagenesis studies, in which the mutant of Arg60Leu completely lost activity in increasing intracellular calcium level through Gq coupling, and the mutant of Arg60Lys retained only about 35% signaling activity. The difference between the side chain functions of Lys and Arg in effecting the signaling was discussed.

[1]  M. Caron,et al.  Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. , 1988, The Journal of biological chemistry.

[2]  M. Walsh,et al.  Investigation of the role of the carboxyl-terminal tails of the α and β isoforms of the human thromboxane A2 receptor (TP) in mediating receptor:effector coupling , 2000 .

[3]  K. Wüthrich.  NMR of proteins and nucleic acids , 1988 .

[4]  Dawei Li,et al.  Identification of Residues Important for Ligand Binding of Thromboxane A2 Receptor in the Second Extracellular Loop Using the NMR Experiment-guided Mutagenesis Approach* , 2003, The Journal of Biological Chemistry.

[5]  K Wüthrich,et al.  Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance. , 1983, Journal of molecular biology.

[6]  Richard R. Ernst,et al.  Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy , 1983 .

[7]  M. Billeter,et al.  Calibration of the angular dependence of the amide proton-Cα proton coupling constants, 3JHNα, in a globular protein: Use of 3JHNα for identification of helical secondary structure , 1984 .

[8]  J. Villafranca,et al.  Techniques in Protein Chemistry II , 1991 .

[9]  V. Bystrov.  Spin—spin coupling and the conformational states of peptide systems , 1976 .

[10]  D. Clapham.  Mutations in G protein-linked receptors: Novel insights on disease , 1993, Cell.

[11]  T. Minegishi,et al.  A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty , 1993, Nature.

[12]  J. Meyer-Kirchrath,et al.  The bovine thromboxane A2 receptor: molecular cloning, expression, and functional characterization , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[13]  B. O'dowd,et al.  D1 dopamine receptor activity is not altered by a mutation in the first intracellular loop. , 1998, Biochimica et biophysica acta.

[14]  S. Narumiya,et al.  Purification of the thromboxane A2/prostaglandin H2 receptor from human blood platelets. , 1989, The Journal of biological chemistry.

[15]  D. Bichet,et al.  Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus , 1992, Nature.

[16]  G. Nicastro,et al.  Structure of the C-terminal Fragment 300-320 of the Rat Angiotensin II AT1A Receptor and Its Relevance with Respect to G-Protein Coupling* , 1997, The Journal of Biological Chemistry.

[17]  H. Deng,et al.  Identification of the residues in the helix F/G loop important to catalytic function of membrane-bound prostacyclin synthase. , 2003, Biochemistry.

[18]  M. Birnbaumer,et al.  Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase. , 1993, The Journal of biological chemistry.

[19]  I. Nishimoto,et al.  Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. , 1992, The Journal of biological chemistry.

[20]  L. Weinstein,et al.  Abnormalities in G protein-coupled signal transduction pathways in human disease. , 1993, The Journal of clinical investigation.

[21]  T. Sakmar,et al.  Characterization of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Mutations on the cytoplasmic surface affect transducin activation. , 1993, The Journal of biological chemistry.

[22]  L. Takemoto,et al.  C-terminal peptides of rhodopsin. Determination of the optimum sequence for recognition of retinal transducin. , 1986, The Biochemical journal.

[23]  L. Reichert,et al.  A synthetic peptide corresponding to residues 645–653 in the carboxyl terminal cytoplasmic domain of the rat testicular follicle stimulating hormone receptor modulates G protein coupled-receptor signaling in rat testis membranes and in intact cultured rat Sertoli cells , 1995, Molecular and Cellular Endocrinology.

[24]  H H Tai,et al.  Site-directed mutagenesis of cysteinyl and serine residues of human thromboxane A2 receptor in insect cells. , 1996, Archives of biochemistry and biophysics.

[25]  S. Narumiya,et al.  Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. , 1994, The Journal of clinical investigation.

[26]  H. Tai,et al.  Phenylalanine 138 in the second intracellular loop of human thromboxane receptor is critical for receptor-G-protein coupling. , 1999, Biochemical and biophysical research communications.

[27]  P. Hargrave,et al.  Three cytoplasmic loops of rhodopsin interact with transducin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Bernier,et al.  A Synthetic Peptide Derived from a COOH-terminal Domain of the Insulin Receptor Specifically Enhances Insulin Receptor Signaling* , 1996, The Journal of Biological Chemistry.

[29]  Jie Ren,et al.  First Intracellular Loop of the Human Cholecystokinin-A Receptor Is Essential for Cyclic AMP Signaling in Transfected HEK-293 Cells* , 1997, The Journal of Biological Chemistry.

[30]  G. L. Le Breton,et al.  Identification of Gq as one of the G-proteins which copurify with human platelet thromboxane A2/prostaglandin H2 receptors. , 1993, The Journal of biological chemistry.

[31]  K. Kent,et al.  Additions and Corrections to Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. , 1994, The Journal of Biological Chemistry.

[32]  S. Narumiya,et al.  Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. , 1996, The Journal of clinical investigation.

[33]  C. Nabhan,et al.  The alternatively spliced type II corticotropin-releasing factor receptor, stably expressed in LLCPK-1 cells, is not well coupled to the G protein(s). , 1995, Biochemical and biophysical research communications.

[34]  P. Wright,et al.  Complete assignment of the 1H nuclear magnetic resonance spectrum of French bean plastocyanin. Application of an integrated approach to spin system identification in proteins. , 1988, Journal of molecular biology.

[35]  Richard R. Ernst,et al.  Investigation of exchange processes by two‐dimensional NMR spectroscopy , 1979 .

[36]  P. Majerus.  Arachidonate metabolism in vascular disorders. , 1983, The Journal of clinical investigation.

[37]  F. Kuehl,et al.  Endothelial cell prostacyclin production induced by activated neutrophils. , 1985, The Journal of biological chemistry.

[38]  A. Shenker,et al.  The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family. , 1991, Transactions of the Association of American Physicians.

[39]  J. Dias.  Human follitropin heterodimerization and receptor binding structural motifs: identification and analysis by a combination of synthetic peptide and mutagenesis approaches , 1996, Molecular and Cellular Endocrinology.

[40]  M. Anand-Srivastava,et al.  Cytoplasmic Domain of Natriuretic Peptide Receptor-C Inhibits Adenylyl Cyclase , 1996, The Journal of Biological Chemistry.

[41]  Nora L. Sullivan,et al.  Mapping of a Ligand-binding Site for the Human Thromboxane A2 Receptor Protein* , 2002, The Journal of Biological Chemistry.

[42]  R. Lefkowitz.  Turned on to ill effect , 1993, Nature.

[43]  K. Catt,et al.  Mediation of Cyclic AMP Signaling by the First Intracellular Loop of the Gonadotropin-releasing Hormone Receptor* , 1998, The Journal of Biological Chemistry.

[44]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[45]  E. Pebay-Peyroula,et al.  X-ray structure of bacteriorhodopsin at 2.5 angstroms from microcrystals grown in lipidic cubic phases. , 1997, Science.

[46]  S. Nakanishi,et al.  Cloning and expression of cDNA for a human thromboxane A2 receptor , 1991, Nature.

[47]  Y. Sugimoto,et al.  Molecular mechanisms of diverse actions of prostanoid receptors. , 1995, Biochimica et biophysica acta.

[48]  J. Wu,et al.  Solution structure of the second extracellular loop of human thromboxane A2 receptor. , 2001, Biochemistry.

[49]  A. Bax,et al.  Optimization of two-dimensional homonuclear relayed coherence transfer NMR spectroscopy , 1985 .

[50]  S W Englander,et al.  Main-chain-directed strategy for the assignment of 1H NMR spectra of proteins. , 1987, Biochemistry.

[51]  B. Kinsella,et al.  Thromboxane A2 signalling in humans: a 'Tail' of two receptors. , 2001, Biochemical Society transactions.

[52]  D. Oprian,et al.  Constitutively active mutants of rhodopsin , 1992, Neuron.

[53]  F. Richards,et al.  The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. , 1992, Biochemistry.